The Use of Expert Surrogates to Evaluate Clinical Trials in Non-Small Cell Lung Cancer

British Journal of Cancer- United Kingdom

doi 10.1038/bjc.1986.224

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Taxotere: Clinical Trials in Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

A Review of Clinical Trials of Cetuximab Combined With Radiotherapy for Non-Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Defining Oligometastatic Non-Small Cell Lung Cancer: A Simulated Multidisciplinary Expert Opinion

European Journal of Cancer
Cancer ResearchOncology
2019English

Potential Clinical Application of lncRNAs in Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Non-Small Cell Lung Cancer

English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Use of Pet in the Management of Non-Small-Cell Lung Cancer in Canada

Current Oncology
Oncology
2014English

Clinical Outcome of Node-Negative Oligometastatic Non-Small Cell Lung Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2016English

What Phase III Trials Are Needed to Improve the Treatment of Advanced Non-Small-Cell Lung Cancer?

Nature Clinical Practice Oncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy